Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1297

1.

Co-carcinogenic effects of vitamin E in prostate.

Vivarelli F, Canistro D, Cirillo S, Papi A, Spisni E, Vornoli A, Croce CMD, Longo V, Franchi P, Filippi S, Lucarini M, Zanzi C, Rotondo F, Lorenzini A, Marchionni S, Paolini M.

Sci Rep. 2019 Aug 12;9(1):11636. doi: 10.1038/s41598-019-48213-1.

2.

MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes.

Casadei L, Calore F, Braggio DA, Zewdu A, Deshmukh AA, Fadda P, Lopez G, Wabitsch M, Song C, Leight JL, Grignol VP, Lev D, Croce CM, Pollock RE.

Cancer Res. 2019 Oct 1;79(19):4911-4922. doi: 10.1158/0008-5472.CAN-19-0203. Epub 2019 Aug 6.

PMID:
31387924
3.

The combination of TPL2 knockdown and TNFα causes synthetic lethality via caspase-8 activation in human carcinoma cell lines.

Serebrennikova OB, Paraskevopoulou MD, Aguado-Fraile E, Taraslia V, Ren W, Thapa G, Roper J, Du K, Croce CM, Tsichlis PN.

Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14039-14048. doi: 10.1073/pnas.1901465116. Epub 2019 Jun 25.

PMID:
31239343
4.

Correction: Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.

Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB.

J Biol Chem. 2019 Jun 21;294(25):10018. doi: 10.1074/jbc.AAC119.009552. No abstract available.

5.

HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia.

Pagotto S, Veronese A, Soranno A, Balatti V, Ramassone A, Guanciali-Franchi PE, Palka G, Innocenti I, Autore F, Rassenti LZ, Kipps TJ, Mariani-Costantini R, Laurenti L, Croce CM, Visone R.

Cancers (Basel). 2019 Apr 23;11(4). pii: E575. doi: 10.3390/cancers11040575.

6.

Experimental Validation of MicroRNA Targets: Analysis of MicroRNA Targets Through Western Blotting.

Tomasello L, Cluts L, Croce CM.

Methods Mol Biol. 2019;1970:341-353. doi: 10.1007/978-1-4939-9207-2_19.

PMID:
30963502
7.

Experimental Validation of MicroRNA Targets: Mutagenesis of Binding Regions.

Tomasello L, Cluts L, Croce CM.

Methods Mol Biol. 2019;1970:331-339. doi: 10.1007/978-1-4939-9207-2_18.

PMID:
30963501
8.

Experimental Validation of MicroRNA Targets: Luciferase Reporter Assay.

Tomasello L, Cluts L, Croce CM.

Methods Mol Biol. 2019;1970:315-330. doi: 10.1007/978-1-4939-9207-2_17.

PMID:
30963500
9.

Investigating miRNA-lncRNA Interactions: Computational Tools and Resources.

Veneziano D, Marceca GP, Di Bella S, Nigita G, Distefano R, Croce CM.

Methods Mol Biol. 2019;1970:251-277. doi: 10.1007/978-1-4939-9207-2_14.

PMID:
30963497
10.

isoTar: Consensus Target Prediction with Enrichment Analysis for MicroRNAs Harboring Editing Sites and Other Variations.

Distefano R, Nigita G, Veneziano D, Romano G, Croce CM, Acunzo M.

Methods Mol Biol. 2019;1970:211-235. doi: 10.1007/978-1-4939-9207-2_12.

PMID:
30963495
11.

Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.

Druck T, Cheung DG, Park D, Trapasso F, Pichiorri F, Gaspari M, Palumbo T, Aqeilan RI, Gaudio E, Okumura H, Iuliano R, Raso C, Green K, Huebner K, Croce CM.

Cell Death Dis. 2019 Feb 15;10(3):147. doi: 10.1038/s41419-019-1414-7.

12.

ncRNA Editing: Functional Characterization and Computational Resources.

Nigita G, Marceca GP, Tomasello L, Distefano R, Calore F, Veneziano D, Romano G, Nana-Sinkam SP, Acunzo M, Croce CM.

Methods Mol Biol. 2019;1912:133-174. doi: 10.1007/978-1-4939-8982-9_6. Review.

PMID:
30635893
13.

WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs.

Khawaled S, Suh SS, Abdeen SK, Monin J, Distefano R, Nigita G, Croce CM, Aqeilan RI.

Cancer Res. 2019 Apr 15;79(8):1784-1798. doi: 10.1158/0008-5472.CAN-18-0614. Epub 2019 Jan 8.

PMID:
30622118
14.

Noncoding RNA genes in cancer pathogenesis.

Pekarsky Y, Croce CM.

Adv Biol Regul. 2019 Jan;71:219-223. doi: 10.1016/j.jbior.2018.12.002. Epub 2018 Dec 13. Review.

PMID:
30611710
15.

Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.

Bertagnolo V, Grassilli S, Volinia S, Al-Qassab Y, Brugnoli F, Vezzali F, Lambertini E, Palomba M, Piubello Q, Orvieto E, Natali C, Piva R, Croce CM, Capitani S.

Mol Carcinog. 2019 May;58(5):708-721. doi: 10.1002/mc.22964. Epub 2019 Jan 16.

16.

Editorial: Epitranscriptomics: The Novel RNA Frontier.

Nigita G, Acunzo M, Cho WCS, Croce CM.

Front Bioeng Biotechnol. 2018 Dec 4;6:191. doi: 10.3389/fbioe.2018.00191. eCollection 2018. No abstract available.

17.

Retraction: Haploinsufficiency of the Hmga1 Gene Causes Cardiac Hypertrophy and Myelo-Lymphoproliferative Disorders in Mice.

Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJP, Visone R, De Martino I, Curcio A, Morisco C, Del Vecchio L, Baldassarre G, Arra C, Viglietto G, Indolfi C, Croce CM, Fusco A.

Cancer Res. 2018 Dec 15;78(24):6908. doi: 10.1158/0008-5472.CAN-18-3457. No abstract available.

PMID:
30552126
18.

miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC.

Jeon YJ, Kim T, Park D, Nuovo GJ, Rhee S, Joshi P, Lee BK, Jeong J, Suh SS, Grotzke JE, Kim SH, Song J, Sim H, Kim Y, Peng Y, Jeong Y, Garofalo M, Zanesi N, Kim J, Liang G, Nakano I, Cresswell P, Nana-Sinkam P, Cui R, Croce CM.

Nat Commun. 2018 Nov 30;9(1):5110. doi: 10.1038/s41467-018-07561-8.

19.

Knockout of both miR-15/16 loci induces acute myeloid leukemia.

Lovat F, Fassan M, Sacchi D, Ranganathan P, Palamarchuk A, Bill M, Karunasiri M, Gasparini P, Nigita G, Distefano R, Veneziano D, Dorrance AM, Garzon R, Croce CM.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13069-13074. doi: 10.1073/pnas.1814980115. Epub 2018 Nov 26.

20.

miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis.

Fassan M, Cui R, Gasparini P, Mescoli C, Guzzardo V, Vicentini C, Munari G, Loupakis F, Lonardi S, Braconi C, Scarpa M, D'Angelo E, Pucciarelli S, Angriman I, Agostini M, D'Incá R, Farinati F, Gafà R, Lanza G, Frankel WL, Croce CM, Valeri N, Rugge M.

Transl Oncol. 2019 Feb;12(2):282-291. doi: 10.1016/j.tranon.2018.10.013. Epub 2018 Nov 16.

21.

Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.

Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M.

Oncogene. 2019 Jan;38(5):765-766. doi: 10.1038/s41388-018-0560-1.

PMID:
30397238
22.

Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.

Fong LY, Jing R, Smalley KJ, Wang ZX, Taccioli C, Fan S, Chen H, Alder H, Huebner K, Farber JL, Fiehn O, Croce CM.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11091-E11100. doi: 10.1073/pnas.1813956115. Epub 2018 Nov 5.

23.

Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.

Carbone M, Amelio I, Affar EB, Brugarolas J, Cannon-Albright LA, Cantley LC, Cavenee WK, Chen Z, Croce CM, Andrea A, Gandara D, Giorgi C, Jia W, Lan Q, Mak TW, Manley JL, Mikoshiba K, Onuchic JN, Pass HI, Pinton P, Prives C, Rothman N, Sebti SM, Turkson J, Wu X, Yang H, Yu H, Melino G.

Cell Death Differ. 2018 Nov;25(11):1885-1904. doi: 10.1038/s41418-018-0213-5. Epub 2018 Oct 15. Review.

PMID:
30323273
24.

MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene.

Balatti V, Oghumu S, Bottoni A, Maharry K, Cascione L, Fadda P, Parwani A, Croce C, Iwenofu OH.

Head Neck Pathol. 2019 Sep;13(3):344-354. doi: 10.1007/s12105-018-0971-x. Epub 2018 Sep 26.

25.

miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients.

Balatti V, Tomasello L, Rassenti LZ, Veneziano D, Nigita G, Wang HY, Thorson JA, Kipps TJ, Pekarsky Y, Croce CM.

Blood. 2018 Nov 15;132(20):2179-2182. doi: 10.1182/blood-2018-04-845115. Epub 2018 Sep 21.

PMID:
30242085
26.

The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.

Calore F, Londhe P, Fadda P, Nigita G, Casadei L, Marceca GP, Fassan M, Lovat F, Gasparini P, Rizzotto L, Zanesi N, Jackson D, Mehta S, Nana-Sinkam P, Sampath D, Pollock RE, Guttridge DC, Croce CM.

Cancer Res. 2018 Dec 1;78(23):6680-6690. doi: 10.1158/0008-5472.CAN-17-3878. Epub 2018 Sep 12.

27.

RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients.

Tessari A, Parbhoo K, Pawlikowski M, Fassan M, Rulli E, Foray C, Fabbri A, Embrione V, Ganzinelli M, Capece M, Campbell MJ, Broggini M, La Perle K, Farina G, Cole S, Marabese M, Hernandez M, Amann JM, Pruneri G, Carbone DP, Garassino MC, Croce CM, Palmieri D, Coppola V.

Oncogene. 2018 Dec;37(50):6463-6476. doi: 10.1038/s41388-018-0424-8. Epub 2018 Aug 3.

28.

MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.

Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zamò A.

Oncotarget. 2018 Jul 3;9(51):29753-29771. doi: 10.18632/oncotarget.25707. eCollection 2018 Jul 3.

29.

MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma.

Pettit C, Webb A, Walston S, Chatterjee M, Chen W, Frankel W, Croce C, Williams TM.

Oncotarget. 2018 Jun 22;9(48):28951-28964. doi: 10.18632/oncotarget.25652. eCollection 2018 Jun 22.

30.

Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.

Nigita G, Distefano R, Veneziano D, Romano G, Rahman M, Wang K, Pass H, Croce CM, Acunzo M, Nana-Sinkam P.

Sci Rep. 2018 Jul 5;8(1):10222. doi: 10.1038/s41598-018-28528-1.

31.

MiR-155 deletion reduces ischemia-induced paralysis in an aortic aneurysm repair mouse model: Utility of immunohistochemistry and histopathology in understanding etiology of spinal cord paralysis.

Awad H, Bratasz A, Nuovo G, Burry R, Meng X, Kelani H, Brown M, Ramadan ME, Williams J, Bouhliqah L, Popovich PG, Guan Z, Mcallister C, Corcoran SE, Kaspar B, Michele Basso D, Otero JJ, Kirsch C, Davis IC, Croce CM, Michaille JJ, Tili E.

Ann Diagn Pathol. 2018 Oct;36:12-20. doi: 10.1016/j.anndiagpath.2018.06.002. Epub 2018 Jun 18.

32.

Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.

Baldassari F, Zerbinati C, Galasso M, Corrà F, Minotti L, Agnoletto C, Previati M, Croce CM, Volinia S.

Front Genet. 2018 May 18;9:174. doi: 10.3389/fgene.2018.00174. eCollection 2018.

33.

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.

Volinia S, Bertagnolo V, Grassilli S, Brugnoli F, Manfrini M, Galasso M, Scatena C, Mazzanti CM, Lessi F, Naccarato G, Caligo A, Bianchini E, Piubello Q, Orvieto E, Rugge M, Natali C, Reale D, Vecchione A, Warner S, Croce CM, Capitani S.

Oncotarget. 2018 May 4;9(34):23543-23553. doi: 10.18632/oncotarget.25261. eCollection 2018 May 4.

34.

MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma.

Malpeli G, Barbi S, Greco C, Zupo S, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Scarpa A, Zamò A.

Oncotarget. 2018 Apr 13;9(28):19961-19979. doi: 10.18632/oncotarget.24987. eCollection 2018 Apr 13.

35.

Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin.

Drusco A, Fadda P, Nigita G, Fassan M, Bottoni A, Gardiman MP, Sacchi D, Calore F, Carosi M, Antenucci A, Casini B, Kelani H, Pescarmona E, Di Leva G, Zanesi N, Berger MS, Croce CM.

EBioMedicine. 2018 Apr;30:105-112. doi: 10.1016/j.ebiom.2018.03.022. Epub 2018 Mar 21.

36.

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.

Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, Bassi C, Lupini L, Sattari A, Cheung D, Veneziano D, Nigita G, Shankaraiah RC, Portolani N, Carcoforo P, Fornari F, Bolondi L, Frassoldati A, Sabbioni S, Colombo M, Croce CM, Negrini M.

Oncotarget. 2018 Feb 27;9(20):15350-15364. doi: 10.18632/oncotarget.24601. eCollection 2018 Mar 16.

37.

Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation.

Pagotto S, Veronese A, Soranno A, Lanuti P, Di Marco M, Russo MV, Ramassone A, Marchisio M, Simeone P, Guanciali-Franchi PE, Palka G, Costantini RM, Croce CM, Visone R.

Oncotarget. 2018 Feb 7;9(16):13036-13047. doi: 10.18632/oncotarget.24437. eCollection 2018 Feb 27.

38.

Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.

Martín-López J, Gasparini P, Coombes K, Croce CM, Boivin GP, Fishel R.

Oncotarget. 2017 Dec 31;9(16):12554-12561. doi: 10.18632/oncotarget.23792. eCollection 2018 Feb 27.

39.

Loss of miR-204 expression is a key event in melanoma.

Galasso M, Morrison C, Minotti L, Corrà F, Zerbinati C, Agnoletto C, Baldassari F, Fassan M, Bartolazzi A, Vecchione A, Nuovo GJ, Di Leva G, D'Atri S, Alvino E, Previati M, Nickoloff BJ, Croce CM, Volinia S.

Mol Cancer. 2018 Mar 9;17(1):71. doi: 10.1186/s12943-018-0819-8.

40.

Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation".

Melillo RM, Pierantoni GM, Scala S, Battista S, Fedele M, Stella A, De Biasio MC, Chiappetta G, Fidanza V, Condorelli G, Santoro M, Croce CM, Viglietto G, Fusco A.

Mol Cell Biol. 2018 Feb 27;38(6). pii: e00660-17. doi: 10.1128/MCB.00660-17. Print 2018 Mar 15. No abstract available.

41.

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.

Ngankeu A, Ranganathan P, Havelange V, Nicolet D, Volinia S, Powell BL, Kolitz JE, Uy GL, Stone RM, Kornblau SM, Andreeff M, Croce CM, Bloomfield CD, Garzon R.

Oncotarget. 2017 Dec 12;9(4):4354-4365. doi: 10.18632/oncotarget.23150. eCollection 2018 Jan 12.

42.

Friend or Foe: MicroRNAs in the p53 network.

Luo Z, Cui R, Tili E, Croce C.

Cancer Lett. 2018 Apr 10;419:96-102. doi: 10.1016/j.canlet.2018.01.013. Epub 2018 Jan 9. Review.

PMID:
29330109
43.

Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis.

Kim T, Croce CM.

Cancer Lett. 2018 Mar 28;417:89-95. doi: 10.1016/j.canlet.2017.12.033. Epub 2018 Jan 3. Review.

44.

HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis.

Lai HH, Li JN, Wang MY, Huang HY, Croce CM, Sun HL, Lyu YJ, Kang JW, Chiu CF, Hung MC, Suzuki HI, Chen PS.

J Clin Invest. 2018 Feb 1;128(2):625-643. doi: 10.1172/JCI89212. Epub 2017 Dec 18.

45.

Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.

Pi F, Binzel DW, Lee TJ, Li Z, Sun M, Rychahou P, Li H, Haque F, Wang S, Croce CM, Guo B, Evers BM, Guo P.

Nat Nanotechnol. 2018 Jan;13(1):82-89. doi: 10.1038/s41565-017-0012-z. Epub 2017 Dec 11.

46.

MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.

Tili E, Michaille JJ, Piurowski V, Rigot B, Croce CM.

Curr Opin Pharmacol. 2017 Dec;37:142-150. doi: 10.1016/j.coph.2017.10.010. Epub 2017 Nov 15. Review.

47.

Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neoplasia.

Fong LY, Jing R, Smalley KJ, Taccioli C, Fahrmann J, Barupal DK, Alder H, Farber JL, Fiehn O, Croce CM.

Oncotarget. 2017 Jun 9;8(47):81910-81925. doi: 10.18632/oncotarget.18434. eCollection 2017 Oct 10.

48.

MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.

Lampis A, Carotenuto P, Vlachogiannis G, Cascione L, Hedayat S, Burke R, Clarke P, Bosma E, Simbolo M, Scarpa A, Yu S, Cole R, Smyth E, Mateos JF, Begum R, Hezelova B, Eltahir Z, Wotherspoon A, Fotiadis N, Bali MA, Nepal C, Khan K, Stubbs M, Hahne JC, Gasparini P, Guzzardo V, Croce CM, Eccles S, Fassan M, Cunningham D, Andersen JB, Workman P, Valeri N, Braconi C.

Gastroenterology. 2018 Mar;154(4):1066-1079.e5. doi: 10.1053/j.gastro.2017.10.043. Epub 2017 Nov 4.

49.

Screening and identification of major phytochemical compounds in seeds, sprouts and leaves of Tuscan black kale Brassica oleracea (L.) ssp acephala (DC) var. sabellica L.

Giorgetti L, Giorgi G, Cherubini E, Gervasi PG, Della Croce CM, Longo V, Bellani L.

Nat Prod Res. 2018 Jul;32(14):1617-1626. doi: 10.1080/14786419.2017.1392953. Epub 2017 Oct 23.

PMID:
29058468
50.

TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line.

Gaudio E, Paduano F, Pinton S, D'Agostino S, Rocca R, Costa G, Ngankeu A, Aqeilan RI, Croce CM, Bertoni F, Alcaro S, Trapasso F.

Br J Haematol. 2018 Nov;183(3):509-512. doi: 10.1111/bjh.14989. Epub 2017 Oct 19. No abstract available.

PMID:
29048125

Supplemental Content

Support Center